1 / 13

Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

Characteristics of Large Prospective Randomized Controlled Statin Trials Included in the Present Analysis. Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18. Relationship Between Rates of Elevated Liver Enzymes and % LDL-C Reduction. Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18.

bruis
Download Presentation

Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Characteristics of Large Prospective Randomized Controlled Statin Trials Included in the Present Analysis Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

  2. Relationship Between Rates of Elevated Liver Enzymes and % LDL-C Reduction Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

  3. Relationship Between Rates of Rhabdomyolysis and % LDL-C Reduction Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

  4. Rate of Elevated Liver Enzymes by Statin Dose Category Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

  5. Rate of Elevated Liver Enzymes by Lovastatin Dose Category Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

  6. Rate of Elevated Liver Enzymes by Simvastatin Dose Category Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

  7. Rate of Elevated Liver Enzymes by Atorvastatin Dose Category Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

  8. Characteristics of Large Prospective Randomized Controlled Statin Trials in Which Incident Cancer Rates Were Reported, and Used for the Present Analysis Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

  9. Relationship Between Rates of Newly Diagnosed Cancer per 100,000 Person-Years and % LDL-C Reduction Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

  10. Relationship Between Rates of Newly Diagnosed Cancer per 100,000 Person-Years and Absolute LDL-C Reduct Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

  11. Relationship Between Rates of Newly Diagnosed Cancer per 100,000 Person-Years and Achieved LDL-C Level Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

  12. Rate of Newly Diagnosed Cancer by Statin Dose Category Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

  13. References Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

More Related